Select a region to explore where Merck is active around the world or learn more about some of Merck's featured programs below.
North America
South America
Africa
Asia
Europe
Middle East
Merck MECTIZAN Donation Program
Established in 1987, the MECTIZAN® (ivermectin) Donation Program (MDP) is the longest-running disease-specific drug donation program of its kind. When Merck created the MDP, we pledged to donate MECTIZAN to all who need it, for as long as necessary, until river blindness is eliminated as a public health problem. In 1998, Merck expanded the MDP to include the elimination of lymphatic filariasis (also known as elephantiasis) in African countries where the disease co-exists with river blindness. Today, the MDP reaches more than 110 million people each year and continues to grow annually. Select targets to see the countries where treatments have been administered.
Back
Guinea,
Guinea Bissau,
Senegal
Ivory Coast,
Liberia,
Sierra Leone
Benin,
Ghana,
Togo
Burkina Faso,
Mali,
Niger
Central African Republic,
Chad,
Sudan
Cameroon,
Equatorial Guinea,
Nigeria
Angola,
Congo (Brazzaville),
Gabon
Burundi,
Dem. Republic of the Congo,
Rwanda
Ethiopia
Yemen
Tanzania,
Malawi,
Mozambique
Brazil
Colombia
Ecuador
Guatemala
Mexico
Venezuela
Merck Vaccine Network-Africa (MVN-A)
For years, the Merck Vaccine Network-Africa (MVN-A) has been helping to train Expanded Program on Immunization (EPI) health workers in sub-Saharan Africa. Formally endorsed by the GAVI Alliance in 2003, MVN-A also works toward the success of the UN Millennium Development Goals, including reducing the mortality rate among children under five by two-thirds by 2015. Select targets to see the countries Merck is developing training programs.
Back
Kenya
Mali
Uganda
Zambia